<?xml version="1.0" encoding="UTF-8"?>
<p id="Par36">If the early stages of clinical development show promising product safety and efficacy, then the product would progress to later clinical stages of clinical development and potential product licensure. The opportunities to accelerate product licensure are manifold, and these details are beyond the scope of this paper, but some considerations are described here.</p>
